Published online May 21, 2019. doi: 10.3748/wjg.v25.i19.2294
Peer-review started: February 17, 2019
First decision: March 14, 2019
Revised: March 23, 2019
Accepted: March 29, 2019
Article in press: March 30, 2019
Published online: May 21, 2019
Processing time: 94 Days and 12.9 Hours
Congenital peritoneal encapsulation (CPE) is a very rare, congenital condition characterised by the presence of an accessory peritoneal membrane which encases a variable extent of the small bowel. It is unclear how CPE develops, however it is currently understood to be a result of an aberrant adhesion in the peritoneal lining of the physiological hernia in foetal mid-gut development. The condition was first described in 1868, and subsequently there have been only 45 case reports of the phenomenon. No formal, systematised review of CPE has yet been performed, meaning the condition remains poorly understood, underdiagnosed and mismanaged. Diagnosis of CPE remains clinical with important adjuncts provided by imaging and diagnostic laparoscopy. Two thirds of patients present with abdominal pain, likely secondary to sub-acute bowel obstruction. A fixed, asymmetrical distension of the abdomen and differential consistency on abdominal palpation are more specific clinical features present in approximately 10% of cases. CPE is virtually undetectable on plain imaging, and is only detected on 40% of patients with computed tomography scan. Most patients will undergo diagnostic laparotomy to confirm the diagnosis. Management of CPE includes both medical management of the critically-unstable patient and surgical laparotomy, partial peritonectomy and adhesiolysis. Prognosis following prompt surgical treatment is excellent, with a majority of patients being symptom free at follow up. This review summarises the current literature on the aetiology, diagnosis and treatment of this rare disease. We also introduce a novel classification system for encapsulating bowel diseases, which may distinguish CPE from the commoner, more morbid conditions of abdominal cocoon and encapsulating peritoneal sclerosis.
Core tip: Congenital peritoneal encapsulation (CPE) is a very rare congenital disorder characterised by the presence of an accessory peritoneal membrane surrounding the entirety of the small intestine. Though not fully understood, it is thought to arise due to an aberrant peritoneal adhesion during foetal mid-gut development. It is a rare but important cause of undifferentiated abdominal pain and sub-acute small bowel obstruction. We present a comprehensive review of CPE including an international epidemiological focus, diagnosis and treatment. We also describe a novel classification system for encapsulating bowel diseases.
- Citation: Dave A, McMahon J, Zahid A. Congenital peritoneal encapsulation: A review and novel classification system. World J Gastroenterol 2019; 25(19): 2294-2307
- URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2294.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i19.2294
Congenital peritoneal encapsulation (CPE) is a very rare, congenital malformation of the gastro-intestinal tract. It is characterised by the presence of an accessory peritoneal membrane which covers a variable extent of the small bowel. This in turn creates an accessory extra-peritoneal sac in which the bowel is contained. The membrane is morphologically and histologically identical to peritoneum. The condition is often asymptomatic, detected incidentally during routine imaging or surgery and even in posthumous dissection. However, CPE also remains a rare but important cause of recurrent, undifferentiated abdominal pain and sub-acute small bowel obstruction. The condition was first described by Cleland[1] in 1868 as a ‘secondary sac bounded by omentum and meso-colon, and communicating with the general sac by means of a small aperture’. Since this time, it has been described in less than fifty cases. To our knowledge, there has been no prior definitive, systematised review of CPE, and therefore the condition has remained poorly understood, underdiagnosed and mismanaged. This review attempts to integrate all the literature available to provide an understanding of the aetiology, pathology, diagnosis and management of this rare and unusual condition. In addition, we provide a novel classification system for encapsulating bowel diseases, which categorises CPE and the similar phenomena of abdominal cocoon and encapsulating peritoneal sclerosis (EPS) in a histo-morphological manner.
An electronic, systematic search of the literature was performed using several databases, including Medline, PubMED, Scopus and Google Scholar (Figure 1). The search was not limited by English language restriction or by date of publication. The following search terms were used as keywords: “Peritoneal Encapsulation”, “Congenital Peritoneal Encapsulation” and “Abdominal Cocoon”. The electronic search was augmented by means of manual searches of the reference lists of the selected publications. Article titles and abstracts were reviewed independently by two investigators for relevance to CPE. A significant volume of the literature reported cases of the more common abdominal cocoon or EPS, and these were excluded. Most cases of CPE could be identified and included through the abstract alone. If further clarification was required, clinical information, histopathology and photographs were used to determine cases. Full manuscripts of articles were read thoroughly and independently by two investigators, and information was extracted, including age, sex, past medical history, clinical information, diagnostic studies, management, histopathology and follow-up status. In two case reports[2,3] full articles could not be found either by contacting the journal or the relevant authors. In these cases, the abstracts alone were used to gather information. In total, 42 reports[1-42] describing 45 separate cases of CPE were found and collated. Table 1 demonstrates the key demographic and clinical information obtained from the cases.
Case | Ref. | Year | Country | Age | Sex | Clinical Features | Tests | Management | Other |
1 | McMahon et al[23] | 2018 | Australia | 20 | M | Intermittent abdominal pain, distension | CT | Surgical resection of sac | Symptom free recovery |
2 | Wolski et al[41] | 2017 | Poland | 12 | M | Abdominal pain for 1 wk | XR, US | Surgical resection of sac | Post-operative complication of adhesion SBO |
3 | Griffith et al[13] | 2017 | United Kingdom | 12 | M | Abdominal pain and vomiting for 1 wk | XR, US | Surgical resection of sac | Gangrenous acalculous cholecystitis |
4 | Arumugam et al[6] | 2017 | India | 22 | F | Small bowel obstruction, assymetric distension | CT | Surgical resection of sac | |
5 | Zoulamoglou et al[42] | 2016 | Greece | 28 | F | Intermittent abdominal pain for 1 yr, asymmetric distension | XR, CT | Surgical resection of sac | |
6 | Teixeira et al[36] | 2015 | Portugal | 25 | M | Small bowel obstruction. Fixed, assymetrical distension | XR, CT | Surgical resection of sac | |
7 | Stewart et al[35] | 2014 | Australia | 16 | M | Intermittent, chronic abdominal pain | XR, US | Surgical resection of sac | |
8 | Wani et al[40] | 2013 | India | 28 | M | Generalised, intermittent abdominal pain | XR, CT, labs | Surgical resection of sac | |
9 | Naidoo et al[26] | 2013 | India | 40 | M | Stab wound | XR, fluoro, CT | Surgical resection of sac | Stabbing injury |
10 | Mitrousias et al[24] | 2012 | Greece | 78 | F | 3 d of abdominal pain | XR, CT, labs | Surgical resection of sac | Helical pattern on CT |
11 | Shamsuddin et al[30] | 2012 | Pakistan | 16 | F | Small bowel obstruction | XR | Failed conservative. Surgical resection. | Excellent recovery |
12 | Ince et al[15] | 2012 | Turkey | 71 | M | Small bowel obstruction | XR, US, CT | Ileocaecal resection | |
13 | Al-Taan et al[5] | 2010 | United Kingdom | 82 | M | Asymptomatic | Surgical resection of tumour and sac | Bowel cancer | |
14 | Kumara et al[17] | 2009 | Sri Lanka | 44 | F | Cushing’s syndrome secondary to right adrenal tumour | CT | Surgical resection of tumour and sac | Adrenal tumour |
15 | Sherigar et al[31] | 2007 | United Kingdom | 85 | F | Small bowel obstruction | XR, CT | Surgical resection of sac | Patient died from chest sepsis |
16 | Basu et al[9] | 2006 | India | 21 | F | Distension, peritonism | XR, US, labs | Resection of sac, appendix, lavage | 7 yr follow up |
17 | Chew et al[11] | 2006 | Singapore | 38 | M | Small bowel obstruction | XR, CT | Surgical resection of sac | |
18 | Shioya et al[32] | 2005 | Japan | 34 | M | Small bowel obstruction, right inguinal hernia | XR, labs | Surgical resection of sac | Excellent recovery |
19 | Okobia et al[2] | 2001 | Nigeria | 15 | F | Abdominal pain | |||
20 | Mordehai et al[25] | 2001 | Israel | 14 | F | Abdominal pain, vomiting, weight loss | XR, US | Surgical resection of sac | Post-operative ileus |
21 | Naraynsingh et al[27] | 2001 | West Indies | 64 | M | Abdominal pain, fixed asymmetrical distension, differential palpation | Surgical resection of sac | ||
22 | Lee et al[19] | 2000 | South Korea | 22 | F | Abdominal pain, distension | XR, CT, labs | Failed conservative management. Surgical resection of sac | Excellent recovery |
23 | Kyaw et al[18] | 1998 | Singapore | 11 | M | Abdominal pain for 5 d, soft mass left flank | US, CT | Surgical resection of sac | Hydronephrosis |
24 | Casas et al[10] | 1998 | Spain | 43 | M | Intermittent abdominal pain for 6 mo | XR, fluoro, US, CT | Surgical resection of sac | Hydronephrosis. Asymptomatic at 14 mo |
25 | Constantinides et al[12] | 1998 | Italy | 49 | F | Found at autopsy. Intermittent, severe abdominal pain during life. | |||
26 | Adedeji et al[4] | 1994 | United Kingdom | 40 | M | Abdominal pain, peritonism for 1 d | XR, labs | Surgical resection of sac | |
27 | Tsunoda et al[38] | 1993 | Japan | 52 | M | Small bowel obstruction, central abdominal mass | XR, US, CT | Surgical resection of sac | Asymptomatic at 8 mo |
28 | Silva et al[34] | 1992 | Japan | 29 | M | Intermittent abdominal pain, scaphoid abdomen | XR, fluoro, CT, labs | Surgical resection of sac | Patient died due to gangrenous small bowel |
29 | Awasthi et al[8] | 1991 | India | 16 | F | Abdominal pain for 9 mo, distension | XR, fluoro | Surgical resection of sac | Discharged day 6 with resolution of symptoms. |
30 | Arora et al[3] | 1989 | India | F | Abdominal pain | Colorectal cancer | |||
31 | Askew et al[7] | 1988 | United Kingdom | M | Incidental finding during surgery | ||||
32 | Walsh et al[39] | 1988 | Ireland | 82 | M | Small bowel obstruction | XR | ||
33 | Huddy et al[14] | 1988 | United Kingdom | 56 | M | Intermittent abdominal pain | XR | Surgical resection of sac | |
34 | Lifschitz et al[22] | 1987 | Ciskei | 66 | M | Abdominal pain, vomiting, distension for 3 wk | XR, labs | Surgical resection of sac | |
35 | Jamieson et al[16] | 1985 | United Kingdom | Incidental finding during laparotomy | Surgical resection of sac | Colorectal cancer | |||
36 | Sieck et al[33] | 1983 | Saudi Arabia | 14 | F | Nausea, vomiting, distension for 3 mo | XR, fluoro, labs | Surgical resection of sac | Patient had breast cancer |
37 | Sieck et al[33] | 1983 | Saudi Arabia | 65 | F | Intermittent pelvic pain, fever, abdominal distension for 5 yr | Surgical resection of sac | ||
38 | Sayfan et al[29] | 1979 | Israel | 12 | F | Abdominal pain, vomiting for 1 d | XR, labs | Surgical resection of sac | Excellent recovery. Discharged day 7 |
39 | Lewin et al[20] | 1970 | United States | 66 | M | Post-mortem examination. Patient died of acute myocardial infarct. | |||
40 | Thorlaksen et al[37] | 1953 | Canada | 57 | M | Diarrhoea, abdominal pain for several years | XR, labs | Initial conservative management successful. | |
41 | Thorlaksen et al[37] | 1953 | Canada | 53 | M | Incidental finding in asymptomatic patient | XR, labs | Surgical resection of sac | Car accident, intra-abdominal haemmorhage |
42 | Thorlaksen et al[37] | 1953 | Canada | 64 | M | Epigastric pain, constipation for 2 yr | XR, labs | Surgical resection of sac | |
43 | Papez et al[28] | 1932 | United States | 61 | M | Cadaveric dissection | |||
44 | Lickley et al[21] | 1907 | United Kingdom | 52 | M | Autopsy. Asymptomatic during life | |||
45 | Cleland et al[1] | 1868 | Ireland | Cadaveric dissection |
The cause of CPE remains poorly understood, however it likely develops at the time the foetal mid-gut herniates into the umbilical cord at 8-10 wk gestation. The most widely accepted aetiology is attributed to Papez[28], who postulates that it is caused by an aberrant peritoneal adhesion between the linings of the physiological umbilical hernia and the caudal duodenum. Within the cord, the mid-gut is encased by peritoneum which lines the hernia walls like a sack. The neck of this sac is thus intimately adjacent to the caudal duodenum. If an adhesion forms between these peritoneal layers, significant traction forces are placed on the peritoneum which lines the mid-gut at the time the hernia is reduced. This may cause it to peel off and surround the small bowel as an extra-peritoneal accessory sac. This theory successfully explains the morphological resemblance of the membrane to peritoneum and its extra-peritoneal location.
A competing theory by Thorlakson et al[37] suggests that CPE may develop due to an abnormality in the reduction of the physiological hernia. The proximal limb of the hernia (which forms jejunum and ileum) is usually reduced first, naturally occupying the lower left of the abdomen. This causes the dorsal mesentery to be pushed to the left. Following this, the distal limb reduces and passes cranially to lie just caudal the liver. Instead, if the distal limb were to reduce first and inappropriately occupy the lower left quadrant, the proximal limb would be forced more caudally and toward the right. The distal limb would then attempt a migration toward the right iliac fossa, and in doing so its dorsal mesentery would cover the entirety of the proximal limb, thereby forming the peritoneal sac over the mid-gut. However, if this were the case, it would be expected that there would be significant mesenteric abnormalities such as mal-position and mal-rotation, which are not always associated with CPE.
Given the rarity of the condition, the incidence and prevalence of CPE is difficult to quantify. However, CPE does not appear to have any predilection toward particular ethnicities. Table 2 demonstrates the geographic distribution of cases. 42% of cases were reported from Europe, with the most common countries being United Kingdom (n = 8), Israel (n = 2)[25,29], Greece (n = 2)[24,42] and Ireland (n = 2)[1,39]. India has the second highest number of cases after the United Kingdom, with six in total[3,6,8,9,26,40]. The mean age of patients at the time of diagnosis was 40.8 (range 11-85 years). Interestingly, there is a 5:3 male predominance. The mean age of diagnosis for males and females was 46 and 32 respectively. This reflects a differential pattern of presentation between genders. Females are diagnosed earlier, with a majority presenting prior to 30 years. In contrast, males display a bi-modal age distribution, with peak presentations occurring in the 20-30 years and 60-70 year period. Medical co-morbidities of patients were documented in some reports, however it is unclear whether these are causally linked to CPE. Three patients had a diagnosis of co-morbid cancer. Two of these patients had gastro-intestinal cancer[5,16] and one of the breast[33]. One patient had an incomplete situs inversus and congenital epigastric hernia[15] and two patients had co-morbid inguinal hernia[11,32].
Country | Case number |
United Kingdom | 8 |
India | 6 |
Canada | 3 |
Japan | 3 |
Australia | 2 |
Greece | 2 |
Ireland | 2 |
Israel | 2 |
Saudi Arabia | 2 |
Singapore | 2 |
United States | 2 |
Ciskei | 1 |
Italy | 1 |
South Korea | 1 |
Nigeria | 1 |
Pakistan | 1 |
Poland | 1 |
Portugal | 1 |
Spain | 1 |
Sri Lanka | 1 |
Turkey | 1 |
West Indies | 1 |
CPE is one type of a collection of conditions which are characterised by encapsulation of the bowel. We introduce a novel classification system which aims to distinguish CPE from the similar, yet discrete, conditions of abdominal cocoon and EPS (Figure 2). Abdominal cocoon and EPS were first described over 100 years ago by Owtschinnikow[43] and have been aptly reviewed by Danford et al[44]. These are acquired conditions which are characterised by a thick fibro-collagenous encasing of the small and large bowel. As such, they have a different aetiology, pathogenesis, and management to CPE. EPS describes cases of the disease that have known associations or aetiological factors, such as abdominal trauma and peritoneal dialysis. Abdominal cocoon, a term first used by Foo et al[45] in 1976, describes idiopathic cases of this disease with no known aetiological factors. We also introduce a novel, broader term, “Fibrotic Peritoneal Encapsulation (FPE)” or FPE, to denote the entire spectrum of these diseases, both primary and secondary. This term adequately describes both the morphology and histopathology of this disease, differentiating it from CPE.
A robust discussion of FPE, both primary and secondary, is outside the scope of this review, and has been reported elsewhere[44,46-49]. However key differences between fibrotic encapsulating bowel diseases and CPE should be noted as part of forming a differential diagnosis. These are highlighted in Table 3. Firstly FPE is an acquired condition which is far more common than CPE. In most cases, there is a known secondary cause for the disease[44]. The most common of these is peritoneal dialysis[50], in which the annual incidence of FPE varies from 0.14%-2.5%[51,52]. Other causative factors include local irritant factors (abdominal trauma[53], abdominal surgery[54], peritoneal shunts[55], peritoneal tuberculosis[56], peritoneal foreign body[57], intra-peritoneal chemotherapy[58]) and systemic factors (beta blocking agents[59], methotrexate[60], cirrhosis[61], Systemic Lupus Erythematosus[62], malignancy, sarcoidosis[63]). FPE is considered to be an inflammatory process, which leads to scarring and fibrosis of the peritoneal membranes through a process of cytokine and cell-mediated inflammation[64]. Furthermore, FPE tends to be significantly more symptomatic and morbid compared to CPE. Following commencement of peritoneal dialysis, an estimated 20% of patients will develop FPE at 8 years[50]. Patients tend to present with bowel obstruction, and long-standing intermittent abdominal pain. 29% of patients with FPE require emergency surgery at the time of presentation[65], and the mortality at one year is as high as 50%[66]. The morphological and histological pathology is the most definitive differentiating factor of FPE. Morphologically, FPE appears as a thick, firm, fibrotic membrane. It is separate from the peritoneum, but may have significant adhesions to the peritoneum and other surrounding structures. Histologically, FPE is characterised by dense fibro-connective tissue proliferation, chronic inflammatory cell infiltration and dilated lymphatics. This differs to CPE, which is histologically identical to peritoneum, and displays no inflammatory component.
Congenital peritoneal encapsulation | Fibrotic peritoneal encapsulation | |
Aetiology | ||
Cause | Congenital | Acquired |
Trigger | Primary/Idiopathic (abdominal cocoon) or secondary (encapsulating peritoneal sclerosis) | |
Epidemiology | ||
Incidence | 45 cases | Idiopathic: 184 cases Secondary: Based on cause |
Age (yr, range) | 40.8 (11-85) | 34.7 (7-87) |
Sex (M:F) | 5:3 | 2:1 |
Geographical Geography | Europe, Sub-continental Asia | Equatorial regions |
Pathology | ||
Morphology | Identical to peritoneum. Thin, semi-transparent, vascularised, soft. | Similar to scar tissue. Thick, white, firm, fibrotic. |
Histopathology | Identical to peritoneum. Mesothelial lining, fibro-connective tissue. | Dense fibro-connective tissue proliferation, chronic inflammatory cell infiltration and dilated lymphatics |
Manage-ment | ||
Treatment | Peritonectomy, adhesiolysis | Corticosteroids, tamoxifen, peritonectomy |
Prognosis | Excellent. Near complete resolution of symptoms. | Up to 50% mortality at 1 yr following diagnosis. |
Abdominal Cocoon, also called idiopathic FPE, was first described by Foo et al[45] in 1978 as a form of FPE where no established cause can be identified. Foo’s case series reported on three adolescent girls who presented with bowel obstruction and were found to have thick, fibrotic peritoneal membranes at laparotomy. Since that time, approximately 75 case reports of abdominal cocoon have been reported, and have been summarised by Akbulut[67]. The disease is most prevalent in India, China and Turkey and has no obvious gender or age distribution. Though historically abdominal cocoon was thought to affect adolescent girls, more recent studies have shown that it tends to occur mainly in equatorial areas and may be twice as common in males. It has been suggested abdominal cocoon may be caused by ‘subclinical peritonitis’[45], possibly as a result of retrograde menstruation, with a complex interplay with superimposed viral infections, salpingitis and cell mediated tissue damage[68]. This, of course, fails to explain its preponderance in males. Other studies have suggested that perhaps developmental disorders, vascular anomalies or omental hypoplasia[69] may be the basis of the disease.
The diagnosis of CPE remains clinical, though confirmation may be obtained through diagnostic imaging and laparotomy. There is no defining gold-standard for diagnosis of CPE and this means the condition may be underdiagnosed. A proposed diagnostic algorithm is provided in Figure 3, which highlights the key clinical, radiographic and pathological features of CPE.
Symptoms associated with a presentation of CPE very likely reflect the development of an acute or sub-acute small bowel obstruction, with abdominal pain, tenderness, nausea and vomiting being the predominant clinical features. Abdominal pain is the most common cause for presentation in CPE, with 66% (n = 30) of patients reporting sudden or chronic. In these patients, 53% (n = 16) reported similar symptoms in the preceding 12 mo, usually with decreased severity. This implies that CPE may be a cause for undifferentiated, intermittent chronic abdominal pain, and diagnosis is generally delayed. Hence, CPE should be suspected in patients presenting with these symptoms. Many patients also described nausea, vomiting and constipation associated with the onset of abdominal pain. On abdominal examination, abdominal tenderness was described in 58% of patients (n = 26), usually in the peri-umbilical area. Peritoneal irritation (defined as one or more of involuntary guarding, rigidity or rebound tenderness) was described in 27% (n = 12) of cases. Abdominal distension was reported in 40% (n = 18) of cases, and seven cases described bowel sounds as being “high pitched”, “exaggerated: or “hyper-active”. One case described acute compression of the abdominal aorta due to CPE, resulting in extensive small bowel necrosis and death[34].
Two unique clinical features of CPE have been described, which may be more specific and aid a more prompt diagnosis. A fixed, asymmetrical distension of the abdomen was reported in 16% (n = 7) of cases. The distension was considered fixed if it was noted not to vary with peristaltic activity, and likely represents the fixed position of the bowel which is trapped within the accessory membrane. Secondly, a differential consistency of the abdominal wall to palpation has been described in several cases of CPE. It is thought that areas of the bowel which are covered by the membrane tend to be fixed, flat and firm, whilst areas which are outside of the membrane are distended and soft (as in small bowel obstruction).
In seven cases, CPE was found incidentally during surgery in asymptomatic patients. These patients were undergoing abdominal surgery for other reasons: namely, colorectal cancer[5,16], obstructive jaundice[7], right adrenal tumour[17], penetrating stab wound injury[26], tubo-ovarian abscess[33] and intra-abdominal haemorrhage[37]. Four cases of CPE were diagnosed at autopsy in patients who had no reported abdominal symptoms or complaints during life[1,20,21,28].
Though the diagnosis of CPE remains clinical, a variety of imaging modalities may be used to aid in diagnosis. Importantly, these modalities may also screen medically unstable patients for complications of small bowel obstruction, including perforation, haemorrhage and ischemia. The use of plain X-ray has been reported in 30 cases. The majority of films showed signs of small bowel obstruction, with 56% (n = 17) reporting central, dilated loops of small bowel and 33% (n = 7) reporting air fluid levels. Two cases reported the presence of hydronephrosis[10,18]. It should be noted that 23% (n = 7) of cases reported no abnormality on plain films, and hence this modality alone cannot be reliably used to diagnose CPE. The use of contrast with X-Ray was used in 10 studies to better visualise CPE. The majority of fluoroscopic cases demonstrated non-specific features of small bowel obstruction. However, three cases demonstrated a concertina or serpentiform pattern of small bowel arrangement[26,33,36]. This sign occurs when the small bowel is packed tightly on to itself in layers within the accessory sac, such that is resembles a coiled snake or concertina. This sign is more specific to CPE, and if found it should warrant further imaging.
Fifteen reports documented the use of computed tomography (CT). Only 40% (n = 6) of these cases reported radiological evidence of a membranous capsule surrounding the bowel, as seen in Figure 4. Hence, CT scanning may not have the resolution to visualise the accessory sac in all cases, and should remain only an adjunct to a clinical diagnosis. Other features commonly reported in CT scans include dilated loops of bowel in 46% of cases (n = 7), and fluid collection in 12% of cases (n = 2). Mitrousias et al[24] described a novel helical pattern of small bowel within the membranous sac on 3D volume rendered imaging. Ultrasonography has also been used in nine cases, of which four reported no significant abnormalities. Other findings included small bowel dilation, ascites[25], hydronephrosis[10] and gall bladder distension[9].
It is clear that imaging is neither sensitive nor specific in identifying cases of CPE. It should therefore be used only as an adjunct to aid in the diagnosis of CPE. Imaging does, however, maintain an important role in determining the presence and severity of complications in medically unwell patients, such as acute bowel obstruction, perforation, ischaemia and bleeding.
No specific laboratory studies exist for aiding in the diagnosis of CPE. Routine blood tests were reported in 13 studies. In six of these, leucocytosis or raised inflammatory markers were noted. In the remaining seven cases, all blood tests were within normal ranges.
A majority of CPE cases are diagnosed at the time of direct visual inspection during diagnostic laparotomy or laparoscopy, as seen in Figure 5. 69% (n = 31) of cases described the accessory sac in CPE as morphologically similar to that of peritoneum. This is consistent with Papez’s theory of CPE as an accessory peritoneal membrane derived from the umbilical hernia. The membrane is typically semi-transparent, vascularised and thin. This contrasts markedly with the thick, white, fibrotic capsule in FPE. The extent of encapsulation of the small bowel in CPE was reported in most cases. 25 cases reported the sac encasing the entirety of the small bowel. The sac typically starts at the duodeno-jujenal junction, to a point within approximately 10-40 cm of the ileo-caecal junction. Four cases described the accessory sac as covering only a small part of the ileum. In cases of small bowel obstruction, the transition point was typically found at the proximal opening of the accessory membrane.
Histopathology was reported in only 14 of the 42 cases. Four of these cases reported histopathological findings consistent with normal peritoneal tissue. In two of these reports, there were features suggestive of active inflammation. Fibrosis (n = 2), fibrous tissue (n = 3), fibro-connective tissue (n = 1) and fibrovascular tissue (n = 1) were reported in 7 cases. Two of these cases also reported the presence of mesothelial cells. The remaining histopathological reports included non-specific chronic inflammatory changes, membranous and elastic bundles and an isolated report of mesothelium.
Treatment of CPE can be conservative, medical or surgical. Conservative management has only been described in a single case of CPE, which was asymptomatic and diagnosed incidentally on routine imaging. The patient remained well and required no further medical management. Medical management generally involves the resuscitation, stabilisation and treatment of the unstable patient with CPE. This is likely due to acute small bowel obstruction and the potential complications associated with this, including perforation, ischaemia, necrosis and haemorrhage. A majority of patients that were hospitalised with CPE were fasted and received nasogastric decompression, intravenous fluid therapy, intravenous anti-biotics and intravenous proton pump inhibitors.
Surgical management consists of exploratory laparotomy, peritonectomy, adhesiolysis and enterolysis. Excision of the sac is usually performed from along its attachments proximally and distally. This has generally been described as a straightforward procedure, devoid of major intra-operative hazards, likely because the accessory sac is extra-peritoneal. Most importantly, adhesions at the neck of the sac must be carefully resected to ensure complete release of the bowel and prevent bowel obstruction and ischaemia post-operatively. In our experience[23], the most difficult part of the procedure is at the time of releasing the proximal neck of the sac. It may lie adjacent to the duodeno-jejunal flexure, and is hence in close proximity to the superior mesenteric vasculature. Care should be taken in this step to ensure the vessels remain undamaged, whilst ensuring complete resection o the sac and any associated adhesions.
Prognosis following prompt surgical management of CPE is excellent. 14 cases reported excellent post-operative recovery with no complications. Length of hospital stay was recorded in 8 cases, with an average of 13 d, and a range of 6-33 d. Very few papers have reported on long term follow up of patients, with the longest being 7 years of symptom free survival[9]. Two patients died during the initial hospital admission: One patient died due to sepsis secondary to a chest infection[31], and the other died due to extensive bowel necrosis[34]. This latter patient was noted to have extensive gangrenous small bowel at the time of initial laparotomy, presumably due to acute bowel obstruction and compression of the abdominal aorta. On re-look laparotomy after 24 h, the patient went into cardiac arrest and died. Other complications that have been reported with CPE include post-operative ileus[25], bowel obstruction secondary to adhesions[41], biliary fistula[37] and duodenal ulceration requiring resection[37].
CPE is a very rare, congenital condition which has been described in less than fifty cases in the literature. For this reason, it remains poorly understood, underdiagnosed and mismanaged. It is an important consideration in patients with long-standing, undifferentiated, intermittent abdominal pain, and these patients should be investigated appropriately. More rarely, patients can develop acute bowel obstruction due to CPE, and warrant hospitalisation, medical stabilisation and emergency surgical procedures. The diagnosis remains clinical, with several unique clinical findings of CPE including a fixed, asymmetrical abdomen being specific indicators of the disease. Adjuncts such as plain imaging, fluoroscopy, CT scanning and ultrasound may also be used in conjunction to aid in diagnosis. Ultimately, most patients undergo diagnostic laparotomy and excision of the accessory peritoneal layer, which results in an excellent prognosis. It is yet unclear what causes CPE, and further work is required to elucidate this as it may provide insights in better identifying patients at risk, and treating them accordingly.
Manuscript spurce: Unsolicited manuscript
Specialty type: Gastroenterology and hepatology
Country of origin: Australia
Peer-review report classification
Grade A (Excellent): A, A
Grade B (Very good): 0
Grade C (Good): 0
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Jun C, Szilagyi A S-Editor: Yan JP L-Editor: A E-Editor: Ma YJ
1. | Cleland. On an Abnormal Arrangement of the Peritoneum, with Remarks on the Development of the Mesocolon.. West Afr J Med. 1868;201-206. [PubMed] [Cited in This Article: ] |
2. | Okobia MN, Osime U, Evbuomwan I. Congenital peritoneal encapsulation of small intestine: A case report. West Afr J Med. 2001;20:279-281. [PubMed] [Cited in This Article: ] |
3. | Arora PK, Narang R, Sethna KS, Gupta D. Peritoneal encapsulation of small bowel--(a case report). J Postgrad Med. 1989;35:219-221. [PubMed] [Cited in This Article: ] |
4. | Adedeji OA, McAdam WA. Small bowel obstruction due to encapsulation and abnormal artery. Postgrad Med J. 1994;70:132-133. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
5. | Al-Taan OS, Evans MD, Shami JA. An asymptomatic case of peritoneal encapsulation: Case report and review of the literature. Cases J. 2010;3:13. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
6. | Arumugam PK, Dalal AK. Peritoneal encapsulation - an unexpected cause of acute intestinal obstruction. J Visc Surg. 2017;154:303-305. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis (0)] |
7. | Askew G, Sykes PA. Encapsulated small bowel: An anatomical curiosity explained. J R Coll Surg Edinb. 1988;33:224. [PubMed] [Cited in This Article: ] |
8. | Awasthi S, Saraswat VA, Kapoor VK. Peritoneal encapsulation of the small bowel: A rare cause of intestinal obstruction. Am J Gastroenterol. 1991;86:383. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 1.4] [Reference Citation Analysis (0)] |
9. | Basu A, Gupta A, Biswas S. An interesting case of a left paraduodenal hernia with peritoneal encapsulation presenting as acute intestinal obstruction. Hellenic J Surg. 2014;86:109. [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
10. | Casas JD, Mariscal A, Martínez N. Peritoneal encapsulation: CT appearance. AJR Am J Roentgenol. 1998;171:1017-1019. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
11. | Chew MH, Sophian Hadi I, Chan G, Ong HS, Wong WK. A problem encapsulated: The rare peritoneal encapsulation syndrome. Singapore Med J. 2006;47:808-810. [PubMed] [Cited in This Article: ] |
12. | Costantinides F, Di Nunno N, Bernasconi P, Jonjic N, Melato M. A new type of peritoneal encapsulation of the small bowel. Am J Surg Pathol. 1998;22:1297-1298. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
13. | Griffith D, Boal M, Rogers T. Peritoneal encapsulation; a rare cause of bowel obstruction. Ann R Coll Surg Engl. 2017;99:e11-e12. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
14. | Huddy SP, Bailey ME. Small bowel obstruction due to peritoneal encapsulation. Br J Surg. 1988;75:262. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
15. | Ince V, Dirican A, Yilmaz M, Barut B, Ersan V, Yilmaz S. Peritoneal encapsulation in a patient with incomplete situs inversus. J Coll Physicians Surg Pak. 2012;22:659-660. [PubMed] [Cited in This Article: ] |
16. | Jamieson NV. An anatomical curiosity. Ann R Coll Surg Engl. 1985;67:237. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 0.6] [Reference Citation Analysis (1)] |
17. | Kumara TL, Kollure SK. A case of peritoneal encapsulation syndrome. Ceylon Med J. 2009;54:17-18. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis (0)] |
18. | Kyaw K. Left mesocolic hernia or peritoneal encapsulation?--a case report. Singapore Med J. 1998;39:30-31. [PubMed] [Cited in This Article: ] |
19. | Lee S, Kim JC, Yun SS, Choi SH, Lim KW. A Case of Small Bowel Obstruction due to Peritoneal Encapsulation. Korean J Gastroenterol. 2000;35:122-125. [Cited in This Article: ] |
20. | Lewin K, McCarthy LJ. Peritoneal encapsulation of the small intestine. Gastroenterology. 1970;59:270-272. [PubMed] [Cited in This Article: ] |
21. | Lickley JD, Cameron J. Note on a Case of Abnormal Disposition of the Peritoneum. J Anat Physiol. 1906;41:88-90. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 301] [Cited by in F6Publishing: 300] [Article Influence: 2.6] [Reference Citation Analysis (0)] |
22. | Lifschitz O, Tiu J, Sumeruk RA. Peritoneal encapsulation of small intestine. A case report. S Afr Med J. 1987;71:452. [PubMed] [Cited in This Article: ] |
23. | McMahon J, Dave A, Zahid A, Austin K. Peritoneal encapsulation as a cause of chronic recurrent abdominal pain in a young male. J Surg Case Rep. 2018;2018:rjy033. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis (1)] |
24. | Mitrousias V, Alexiou E, Katsanas A, Batzalexis K, Germanos S. The helix sign in the peritoneal encapsulation syndrome: A new sign in a rare cause of bowel obstruction? J Gastrointestin Liver Dis. 2015;24:144. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
25. | Mordehai J, Kleiner O, Kirshtein B, Barki Y, Mares AJ. Peritoneal encapsulation: A rare cause of bowel obstruction in children. J Pediatr Surg. 2001;36:1059-1061. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
26. | Naidoo K, Mewa Kinoo S, Singh B. Small Bowel Injury in Peritoneal Encapsulation following Penetrating Abdominal Trauma. Case Rep Surg. 2013;2013:379464. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
27. | Naraynsingh V, Maharaj D, Singh M, Ramdass MJ. Peritoneal encapsulation: A preoperative diagnosis is possible. Postgrad Med J. 2001;77:725-726. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis (0)] |
28. | Papez JW. A rare intestinal anomaly of embryonic origin. Anat Rec. 1932;54:197-198. [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.2] [Reference Citation Analysis (1)] |
29. | Sayfan J, Adam YG, Reif R. Peritoneal encapsulation in childhood. Case report, embryologic analysis, and review of literature. Am J Surg. 1979;138:725-727. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
30. | Shamsuddin S, Bilal M, Rehman B, Najeeb E, Faisal S. Peritoneal encapsulation presenting as small bowel obstruction in a 16 year old girl. J Ayub Med Coll Abbottabad. 2012;24:215. [PubMed] [Cited in This Article: ] |
31. | Sherigar JM, McFall B, Wali J. Peritoneal encapsulation: Presenting as small bowel obstruction in an elderly woman. Ulster Med J. 2007;76:42-44. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
32. | Shioya T, Shibuya T, Tokunaga A, Matsumoto K. Intestinal obstruction due to peritoneal encapsulation of the small bowel: Report of a case. Nihon Gekakei Rengo Gakkaishi (J Japanese Coll Surg). 2005;30:625-628. [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis (0)] |
33. | Sieck JO, Cowgill R, Larkworthy W. Peritoneal encapsulation and abdominal cocoon. Case reports and a review of the literature. Gastroenterology. 1983;84:1597-1601. [PubMed] [Cited in This Article: ] |
34. | Silva MB, Connolly MM, Burford-Foggs A, Flinn WR. Acute aortic occlusion as a result of extrinsic compression from peritoneal encapsulation. J Vasc Surg. 1992;16:286-289. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
35. | Stewart D, Rampersad R, King SK. Peritoneal encapsulation as a cause for recurrent abdominal pain in a 16-year-old male. ANZ J Surg. 2017;87:414-415. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
36. | Teixeira D, Costa V, Costa P, Alpoim C, Correia P. Congenital peritoneal encapsulation. World J Gastrointest Surg. 2015;7:174-177. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis (0)] |
37. | THORLAKSON PH, MONIE IW, THORLAKSON TK. Anomalous peritoneal encapsulation of the small intestine; a report of three cases. Br J Surg. 1953;40:490-493. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
38. | Tsunoda T, Mochinaga N, Eto T, Furui J, Tomioka T, Takahara H. Sclerosing encapsulating peritonitis combined with peritoneal encapsulation. Arch Surg. 1993;128:353-355. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 0.8] [Reference Citation Analysis (1)] |
39. | Walsh TN, Russell J. Peritoneal encapsulation of the small bowel. Br J Surg. 1988;75:1148. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
40. | Wani I, Wani K, Wani M, Bhat G, Shah M. Peritoneal encapsulation, left paraduodenal hernia with retroperitonealization of inferior mesenteric vein leading to triple obstruction. Int J Case Rep Images. 2013;4:169-174. [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
41. | Wolski M, Żerańska M, Piotrowska A, Pomorska K, Kamiński A. Congenital peritoneal encapsulation – A cause of intestinal strangulation in a child. J Pediatr Surg Case Rep. 2017;21:4-6. [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
42. | Zoulamoglou M, Flessas I, Zarokosta M, Piperos T, Kalles V, Tsiaousis I, Kaklamanos I, Sgantzos M, Mariolis-Sapsakos T. Congenital peritoneal encapsulation of the small intestine: A rare case report. Int J Surg Case Rep. 2016;27:28-31. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
43. | Owtschinnikow P. Peritonitis chronica fibrosa incapsulata. Arch für Klin Chir. 1907;83:623-634. [Cited in This Article: ] |
44. | Danford CJ, Lin SC, Smith MP, Wolf JL. Encapsulating peritoneal sclerosis. World J Gastroenterol. 2018;24:3101-3111. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 77] [Article Influence: 12.8] [Reference Citation Analysis (5)] |
45. | Foo KT, Ng KC, Rauff A, Foong WC, Sinniah R. Unusual small intestinal obstruction in adolescent girls: The abdominal cocoon. Br J Surg. 1978;65:427-430. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 193] [Cited by in F6Publishing: 193] [Article Influence: 4.2] [Reference Citation Analysis (0)] |
46. | Moinuddin Z, Summers A, Van Dellen D, Augustine T, Herrick SE. Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease. Front Physiol. 2015;5:470. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis (0)] |
47. | Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: Definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20 Suppl 4:S43-S55. [PubMed] [Cited in This Article: ] |
48. | Brown MC, Simpson K, Kerssens JJ, Mactier RA; Scottish Renal Registry. Encapsulating peritoneal sclerosis in the new millennium: A national cohort study. Clin J Am Soc Nephrol. 2009;4:1222-1229. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 155] [Cited by in F6Publishing: 134] [Article Influence: 8.9] [Reference Citation Analysis (0)] |
49. | Korte MR, Sampimon DE, Betjes MG, Krediet RT. Encapsulating peritoneal sclerosis: The state of affairs. Nat Rev Nephrol. 2011;7:528-538. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 57] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis (0)] |
50. | Brown EA, Bargman J, van Biesen W, Chang MY, Finkelstein FO, Hurst H, Johnson DW, Kawanishi H, Lambie M, de Moraes TP, Morelle J, Woodrow G. Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update. Perit Dial Int. 2017;37:362-374. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 79] [Cited by in F6Publishing: 88] [Article Influence: 14.7] [Reference Citation Analysis (0)] |
51. | Kawanishi H, Moriishi M. Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit Dial Int. 2005;25 Suppl 4:S14-S18. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
52. | Betjes MG, Habib SM, Boeschoten EW, Hemke AC, Struijk DG, Westerhuis R, Abrahams AC, Korte MR. Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients. Perit Dial Int. 2017;37:230-234. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis (0)] |
53. | Kaur S, Doley RP, Chabbhra M, Kapoor R, Wig J. Post trauma abdominal cocoon. Int J Surg Case Rep. 2015;7C:64-65. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
54. | Kaman L, Iqbal J, Thenozhi S. Sclerosing encapsulating peritonitis: complication of laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A. 2010;20:253-255. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
55. | Sigaroudinia MO, Baillie C, Ahmed S, Mallucci C. Sclerosing encapsulating peritonitis--a rare complication of ventriculoperitoneal shunts. J Pediatr Surg. 2008;43:E31-E33. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis (0)] |
56. | Sharma V, Mandavdhare HS, Rana SS, Singh H, Kumar A, Gupta R. Role of conservative management in tubercular abdominal cocoon: A case series. Infection. 2017;45:601-606. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis (0)] |
57. | Árnadóttir M, Jónasson JG, Indridason ÓS. Encapsulating peritoneal sclerosis following a peritoneal foreign body reaction to Dacron fibres-a case report. NDT Plus. 2011;4:107-109. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
58. | Takebayashi K, Sonoda H, Shimizu T, Ohta H, Ishida M, Mekata E, Endo Y, Tani T, Tani M. Successful surgical approach for a patient with encapsulating peritoneal sclerosis after hyperthermic intraperitoneal chemotherapy: A case report and literature review. BMC Surg. 2014;14:57. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
59. | Eltringham WK, Espiner HJ, Windsor CW, Griffiths DA, Davies JD, Baddeley H, Read AE, Blunt RJ. Sclerosing peritonitis due to practolol: A report on 9 cases and their surgical management. Br J Surg. 1977;64:229-235. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
60. | Sachdev A, Usatoff V, Thaow C. Sclerosing encapsulating peritonitis and methotrexate. Aust N Z J Obstet Gynaecol. 2006;46:58-59. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
61. | Wakabayashi H, Okano K, Suzuki Y. Clinical challenges and images in GI. Image 2. Perforative peritonitis on sclerosing encapsulating peritonitis (abdominal cocoon) in a patient with alcoholic liver cirrhosis. Gastroenterology. 2007;132:854, 1210. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
62. | Pepels MJ, Peters FP, Mebis JJ, Ceelen TL, Hoofwijk AG, Erdkamp FL. Sclerosing peritonitis: An unusual cause of ascites in a patient with systemic lupus erythematosus. Neth J Med. 2006;64:346-349. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
63. | Ngô Y, Messing B, Marteau P, Nouël O, Pasquiou A, Lavergne A, Rambaud JC. Peritoneal sarcoidosis. An unrecognized cause of sclerosing peritonitis. Dig Dis Sci. 1992;37:1776-1780. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
64. | Lambie MR, Chess J, Summers AM, Williams PF, Topley N, Davies SJ; GLOBAL Fluid Study Investigators. Peritoneal inflammation precedes encapsulating peritoneal sclerosis: Results from the GLOBAL Fluid Study. Nephrol Dial Transplant. 2016;31:480-486. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis (0)] |
65. | Li N, Zhu W, Li Y, Gong J, Gu L, Li M, Cao L, Li J. Surgical treatment and perioperative management of idiopathic abdominal cocoon: Single-center review of 65 cases. World J Surg. 2014;38:1860-1867. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 43] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis (0)] |
66. | Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SL, Farrington K, Gallagher H, Harnett P, Krausze S, Steddon S. The Pan-Thames EPS study: Treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24:3209-3215. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 103] [Cited by in F6Publishing: 111] [Article Influence: 7.4] [Reference Citation Analysis (0)] |
67. | Akbulut S. Accurate definition and management of idiopathic sclerosing encapsulating peritonitis. World J Gastroenterol. 2015;21:675-687. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 100] [Article Influence: 11.1] [Reference Citation Analysis (2)] |
68. | Narayanan R, Bhargava BN, Kabra SG, Sangal BC. Idiopathic sclerosing encapsulating peritonitis. Lancet. 1989;2:127-129. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 1.1] [Reference Citation Analysis (0)] |
69. | Xu P, Chen LH, Li YM. Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon): A report of 5 cases. World J Gastroenterol. 2007;13:3649-3651. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis (0)] |